Media

14 Nov 2023

Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023

Read article

06 Nov 2023

JIXING and WuXi STA Announce Strategic Partnership Agreement

Read article

24 Oct 2023

Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil

Read article

18 Oct 2023

JIXING Announces National Medical Products Administration Approval of the Clinical Trial Application for the China Cohort of MAPLE-HCM, the Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients with Symptomatic Obstructive Hypertrophic

Read article

11 Oct 2023

Cytokinetics Presents Baseline Characteristics From SEQUOIA-HCM at the HCM Society Scientific Sessions

Read article

28 Sep 2023

JIXING and Wuzhou Announce Distribution Agreement

Read article

27 Sep 2023

JIXING Announces the First Patient Enrolled in Phase 3 Clinical Study of LNZ100 and LNZ101 for the Treatment of Presbyopia in China

Read article